11 17
1 15 15 11 3a
19 19 49 19 19 30

7f Evans Lab

19 19 19 31 19 65 19 19 49 31 31 19 19 19 19 19 45
40

Sydney Evans, V.M.D., M.S.

1 29

Professor of Radiation Oncology

1 ba

Sydney Evans, V.M.D., M.S.University of Pennsylvania School of Medicine
27 Department of Radiation Oncology
1f 187 John Morgan Building
19 3620 Hamilton Walk
1d Philadelphia, PA 19104
40 (215) 898 - 0072 (Lab)
59 sydevans@pennmedicine.upenn.edu

1 9b

Publications

1 1c

Research Interests

1 689

The primary emphasis of the work in the Evans laboratory is to determine causes of treatment resistance in human cancer. The treatment resistance factor that is emphasized is hypoxia. The presence, level and distribution of hypoxia is measured using a 2-nitroimidazole agent, EF5, developed by Dr. Cameron Koch, also from the Department of Radiation Oncology, at PENN. EF5 can be used for in vitro or in vivo studies. The majority of studies in the Evans laboratory involve in vivo studies in animals or humans. Given intravenously, this agent is reduced and bound in hypoxic cells. The adducts thus formed are recognized by a specific fluorescent monoclonal antibody. Tumor tissue or cells are studied either using immunohistochemistry or flow cytometry. This fluorescence can be measured and converted into tissue pO2 based upon previously published in vitro studies. We have performed studies using EF5 in animal models of cancer and, since 1998 have been performing clinical trials to evaluate the presence and level of hypoxia in various human cancers. We are currently funded by the NIH to perform studies in human brain tumors, head and neck cancers, sarcomas, cervix, and intraperitoneal cancers. We have shown that hypoxia, as measured by EF5 binding correlates to the level of tumor aggression in glial brain tumors, soft tissue sarcomas and head/neck squamous cell cancers. We have recently been able to produce [F-18]-EF5, which can be analyzed with positron emission tomography, PET imaging. Grants to study EF5 binding, with both immunohistochemical and PET endpoints in patients with brain tumors and head and neck cancer have been funded by the NIH.

1 15

Lab Members

1 5
    26
  • Sydney Evans, V.M.D., M.S.
    2f Position in Lab: Principal Investigator
    53 Education: V.M.D., University of Pennsylvania School of Veterinary Medicine
    64 M.S. (Comparative Animal Medicine): University of Pennsylvania School of Veterinary Medicine
    64 Internship (Small Animal Medicine): University of Pennsylvania School of Veterinary Medicine
    35 Residency (Radiology and Radiation Oncology):
    40 University of Pennsylvania School of Veterinary Medicine
    67 Email: sydevans@pennmedicine.upenn.edu
    • 6
1 10

Alumni

1 5
    17
  • Neilay Amin
    32 Former Position in Lab: Student Researcher
    80 Education: Current student, University of Pennsylvania School of Arts and Sciences, Candidate for Bachelor’s in Biology
    • 1d
  • Sarah Clark, B.S.
    3a Former Position in Lab: Animal Research Specialist
    30 Education: Baldwin-Wallace College, 2008
    3c B.S., Psychology, minors in Neuroscience and Biology
    5c Professional Associations: AALAS - American Association for Laboratory Animal Science
    • 29
  • Kevin Jenkins, B.S.E., M.S.E.
    39 Former Position in Lab: Senior Programmer/Analyst
    2d Education: University of Pennsylvania
    57 B.S.E. Computer Science and Engineering, M.S.E. Computer and Information Science
    • 1e
  • Julie Daniel, B.A.
    33 Former Position in Lab: Research Specialist
    2f Education: University of Virginia, 2006
    19 B.A., Neuroscience
    • 1e
  • Alex Kachur, Ph.D.
    27 Email: kachur@mail.med.upenn.edu
    • 1a
  • Xiangyang Yang
    32 Former Position in Lab: Research Specialist
    • 6
1f
19 19 19 31 19 1b
11 15 11 15 25 11 11 11 18
9 13